Aims

To support the free and open dissemination of research findings and information on alcoholism and alcohol-related problems. To encourage open access to peer-reviewed articles free for all to view.

For full versions of posted research articles readers are encouraged to email requests for "electronic reprints" (text file, PDF files, FAX copies) to the corresponding or lead author, who is highlighted in the posting.

___________________________________________

Thursday, August 30, 2007

Substance Abuse Treatment Advisory: Naltrexone

The Center for Substance Abuse Treatment’s (CSAT’s) latest Substance Abuse Treatment Advisory, Naltrexone for Extended-Release Injectable Suspension for Treatment of Alcohol Dependence (Spring 2007, Volume 6, Issue 1) is available now!

Naltrexone for Extended-Release Injectable Suspension for Treatment of Alcohol Dependence (SMA07-4267)

In April 2006, the U.S. Food and Drug Administration approved a new extended-release injectable formulation of naltrexone (Vivitrol®) for the treatment of alcohol dependence. This issue answers questions treatment providers, particularly counselors and program administrators, may have about injectable naltrexone.

Download Issue (PDF)

___________________________________________________________


____________________________________________________________________

at